Economic burden of comorbidities in patients with psoriasis is substantial
Authors:
- 4 January 2011
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 25 (2) , 157-163
Abstract
Background Psoriasis is frequently associated with comorbidities.Objective To estimate the incremental economic burden associated with comorbidities in patients with psoriasis, accounting for psoriasis severity.Methods Patients continuously enrolled ≥ 6 months after a randomly selected psoriasis diagnosis date were selected from the Ingenix Impact National Managed Care Database (1999–2004). Comorbidities identified during the 6‐month study included: psoriatic arthritis, cardiovascular disease, depression, diabetes, hyperlipidemia, hypertension, obesity, cerebrovascular diseases and peripheral vascular disease. Resource utilization and costs during the 6‐month follow‐up period were compared for patients with ≥ 1 comorbidity vs. those without and for patients with a specific comorbidity vs. those without. Adjusted incidence rate ratios (IRRs) and odds ratios (ORs) were estimated for resource utilization using negative binomial and logistic regression models, respectively. Adjusted incremental costs associated with comorbidities were reported using general linear models with log‐link and gamma distributions or two‐part models. Models controlled for age, sex and psoriasis severity.Results A total of 114 512 patients were included; 51% had ≥ 1 comorbidity. Hyperlipidemia (27%) and hypertension (25%) were most prevalent. Patients with comorbidities were more likely to experience urgent care [OR (95% confidence interval (CI)) = 1.58 (1.51–1.65)] than patients without comorbidities. They also had significantly greater hospitalization rates [IRR (95% CI) = 2.27 (2.13–2.42)] and outpatient visits [IRR (95% CI) = 1.53 (1.52–1.55)]. Compared with patients who did not have comorbidities, patients with comorbidities incurred $2184 (P < 0.001) greater total costs.Conclusion Comorbidities present a significant economic burden in patients with psoriasis.Keywords
This publication has 30 references indexed in Scilit:
- The impact of psoriasis on health care costs and patient work lossJournal of the American Academy of Dermatology, 2008
- Psoriasis comorbiditiesJournal of Dermatological Treatment, 2008
- Association between Psoriasis and the Metabolic SyndromeDermatology, 2008
- Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis — a structural equations modeling approachGeneral Hospital Psychiatry, 2007
- Prevalence of cardiovascular risk factors in patients with psoriasisJournal of the American Academy of Dermatology, 2006
- Risk of Myocardial Infarction in Patients With PsoriasisJAMA, 2006
- The importance of disease associations and concomitant therapy for the long-term management of psoriasis patientsArchives of Dermatological Research, 2006
- Quality of life in patients with psoriasisHealth and Quality of Life Outcomes, 2006
- Prevalence of Joint Disease in Patients with PsoriasisAmerican Journal of Clinical Dermatology, 2003
- PSORIATIC ARTHRITIS IN PSORIATIC PATIENTSRheumatology, 1984